- Home
- BMHL vs BYSI Comparison
BMHL vs BYSI Comparison
Compare BMHL & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMHL | BYSI |
|---|---|---|
| Founded | 2016 | 2010 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.5M | 79.0M |
| IPO Year | 2025 | 2017 |
Fundamental Metrics
Financial Performance| Metric | BMHL | BYSI |
|---|---|---|
| Price | $3.65 | $1.78 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 4.4K | ★ 719.0K |
| Earning Date | 01-09-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 9.50 | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $6,873,097.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $62.59 | ★ N/A |
| Revenue Growth | ★ 66.02 | N/A |
| 52 Week Low | $2.72 | $0.98 |
| 52 Week High | $4.49 | $3.44 |
Technical Indicators
Market Signals| Indicator | BMHL | BYSI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.06 |
| Support Level | N/A | $1.82 |
| Resistance Level | N/A | $2.40 |
| Average True Range (ATR) | 0.00 | 0.22 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 0.00 | 10.22 |
Price Performance
Historical ComparisonAbout BMHL Bluemount Holdings Limited Class B Ordinary Shares
Bluemount Holdings Ltd through its operating subsidiaries, it is a Hong Kong-based consulting and advisory and financial services provider, as well as trader of commodities such as luxury timepieces. The financial services includes underwriting and placing services, securities dealing and brokerage services, and asset management services. It provides comprehensive consulting and advisory services on business development strategies to its diverse clientele. Generally, the company provides consulting and advisory business for the following segments: Corporate Finance; and Strategic Communications.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.